Search Within

Curtis Chong

Formats
  1. Meeting Abstract (5)
  2. Journal Article (2)
  3. Book Section (1)
  4. Correspondence (1)
Groups
  1. Department of Medicine (7)
  2. Solid Tumor Oncology Division (6)
  3. Division of Subspecialty Medicine (5)
  4. GSK Faculty (5)
  5. Gastrointestinal Oncology Service (5)
  6. Melanoma and Immunotherapeutics Service (4)

More Groups

People
  1. David Kelsen (3)
  2. Geoffrey Ku (3)
  3. Mini Kamboj (3)
  4. Nikolaus Schultz (3)
  5. Yelena Janjigian (3)
  6. Bevin Cohen (2)

More People

Years
  1. 2024 (1)
  2. 2020 (3)
  3. 2019 (4)
  4. 2018 (1)
Publications
  1. Journal of Clinical Oncology (5)
  2. Clinical Infectious Diseases (2)
  3. Handbook of Gastrointestinal Cancers: Evidence-Based Treatment and Multidisciplinary Patient Care (1)
  4. JAMA Network Open (1)
Publishers
  1. American Society of Clinical Oncology (5)
  2. Oxford University Press (2)
  3. American Medical Association (1)
  4. Demos Medical Publications (1)

Results (9)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Trends in hepatocellular carcinoma mortality rates in the US and projections through 2040
    Journal Article

    Qiu, S.; Cai, J.; Yang, Z.; He, X.; Xing, Z.; Zu, J.; Xie, E.; Henry, L.; Chong, C. R.; John, E. M.; more...
    JAMA Network Open (2024)

    Fulltext@MSK | Save
  • Reply to Groeneveld et al
    Correspondence

    Chong, C. R.; Cohen, B.; Kamboj, M.
    Clinical Infectious Diseases (2020)

    Fulltext@MSK | Save
  • Safety of inactivated influenza vaccine in cancer patients receiving immune checkpoint inhibitors
    Journal Article

    Chong, C. R.; Park, V. J.; Cohen, B.; Postow, M. A.; Wolchok, J. D.; Kamboj, M.
    Clinical Infectious Diseases (2020)

    Fulltext@MSK | Save
  • How I treat metastatic gastric and esophageal cancer with immunotherapy
    Book Section

    Chong, C. R.; Janjigian, Y. Y.
    In Bekaii-Saab, T.; El-Rayes, B. F.; Pawlik, T. M. (Eds.) Handbook of Gastrointestinal Cancers: Evidence-Based Treatment and Multidisciplinary Patient Care (2020)

    Fulltext@MSK | Save
  • Homologous recombination deficiency (HRD): A biomarker for first-line (1L) platinum in advanced pancreatic ductal adenocarcinoma (PDAC)
    Meeting Abstract

    Park, W.; Wong, W.; Yu, K. H.; Varghese, A. M.; Riaz, N.; Balachandran, V. P.; El Dika, I. H.; Raj, N. P.; Khalil, D.; Ku, G. Y.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • First-line pembrolizumab (P), trastuzumab (T), capecitabine (C) and oxaliplatin (O) in HER2-positive metastatic esophagogastric adenocarcinoma
    Meeting Abstract

    Janjigian, Y. Y.; Maron, S. B.; Chou, J. F.; Gabler, A.; Simmons, M.; Momtaz, P.; Sanchez-Vega, F.; Shcherba, M.; Ku, G. Y.; Won, E.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • A phase Ia/Ib, open label, multicenter, dose -escalation study of BI 907828 (MDM2-p53 antagonist) in adult patients with advanced or metastatic solid tumors
    Meeting Abstract

    Chong, C. R.; Bauer, T. M.; Laurie, S. A.; Patel, M. R.; Yamamoto, N.; Davenport, T.; Geng, J.; Gibson, N.; Vallaster, M. P.; LoRusso, P.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • First-line pembrolizumab (P), trastuzumab (T), capecitabine (C) and oxaliplatin (O-) in HER2-positive metastatic esophagogastric adenocarcinoma (mEGA)
    Meeting Abstract

    Janjigian, Y. Y.; Chou, J. F.; Simmons, M.; Momtaz, P.; Sanchez-Vega, F.; Shcherba, M.; Ku, G. Y.; Won, E.; Chong, C. R.; Gerdes, H.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Safety of influenza vaccination in patients undergoing immunotherapy treatment for advanced cancer
    Meeting Abstract

    Chong, C. R.; Park, V.; Harding, J. J.; Brite, J.; Wolchok, J. D.; Kamboj, M.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save